Hospital Variation in Medical and Surgical Treatment of Patent Ductus Arteriosus

Abstract

Objective This study aims to characterize population risks for diagnosis, medical treatment, and surgical ligation of patent ductus arteriosus (PDA) in very low-birth-weight infants.

Study Design Maternal and neonatal data were collected in 40 hospitals in California during 2011 for infants with birth weight ≤ 1,500 g without any congenital malformation, with a diagnosis of PDA. Multivariable logistic regression was used to determine independent risks for PDA diagnosis and for surgical ligation.

Results There were 770/1,902 (40.4%) infants diagnosed with PDA. Low birth weight, gestational age, respiratory distress syndrome, and surfactant administration were associated with PDA diagnosis. Ligation occurred in 43% of patients with birth weight ≤ 750 g, in 24% of patients weighing between 715 and 1,000 g, and in 12% of patients weighing from 1,001 to 1,500 g. Older gestational age (1 week, odds ratio 0.55, 95% confidence interval 0.48–0.63) and absence of respiratory distress syndrome (odds ratio 0.14, 95% confidence interval 0.03–0.59) were associated with lower ligation risk. The median hospital ligation rate was 14% (interquartile range 0–38%).

Conclusion Most patients with PDA receive treatment for closure. Practice variation may set the stage for further exploration of experimental trials.

Keywords

patent ductus arteriosus - ligation - very low birth weight

• References

• 1 Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?. J Perinatol 2010; 30 (4) 241-252
• 2 Jacob J, Gluck L, DiSessa T , et al. The contribution of PDA in the neonate with severe RDS. J Pediatr 1980; 96 (1) 79-87
• 3 Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM ; North Carolina Neonatologists Association. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. Pediatrics 1999; 104 (6) 1345-1350
• 4 Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005; 40 (2) 184-188
• 5 Drougia A, Giapros V, Krallis N , et al. Incidence and risk factors for cerebral palsy in infants with perinatal problems: a 15-year review. Early Hum Dev 2007; 83 (8) 541-547
• 6 Noori S, McCoy M, Friedlich P , et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123 (1) e138-e144
• 7 Edmunds Jr LH, Gregory GA, Heymann MA, Kitterman JA, Rudolph AM, Tooley WH. Surgical closure of the ductus arteriosus in premature infants. Circulation 1973; 48 (4) 856-863
• 8 Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295 (10) 530-533
• 9 Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92 (6) F498-F502
• 10 Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010; 125 (5) 1020-1030
• 11 Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A ; Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007; 150 (3) 229-234 , e1
• 12 Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007; 119 (6) 1165-1174
• 13 Clyman R, Cassady G, Kirklin JK, Collins M, Philips III JB. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009; 154 (6) 873-876
• 14 Rich W, Finer NN, Gantz MG , et al; SUPPORT and Generic Database Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Enrollment of extremely low birth weight infants in a clinical research study may not be representative. Pediatrics 2012; 129 (3) 480-484
• 15 Stark AR ; American Academy of Pediatrics Committee on Fetus and Newborn. Levels of neonatal care. Pediatrics 2004; 114 (5) 1341-1347
• 16 Sallmon H, Weber SC, Hüning B , et al. Thrombocytopenia in the first 24 hours after birth and incidence of patent ductus arteriosus. Pediatrics 2012; 130 (3) e623-e630
• 17 Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2011; (7) CD004213
• 18 Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010; (7) CD000174